Erudio Healtherudio.com
Sponsor
Massachusetts General Hospital trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Massachusetts General Hospital yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by Massachusetts General Hospital: NCT03803553, NCT04292119, NeoSTAR and PARTIQoL. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Massachusetts General Hospital). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| PARTIQoL NCT01617161 · Massachusetts General Hospital DeepView → | low or intermediate risk prostate cancer | Not applicable | Deep | View | |||
| NCT03803553 NCT03803553 · Massachusetts General Hospital FocusedView → | Not given | Phase 3 | Focused | View | |||
| NeoSTAR NCT04230109 · Massachusetts General Hospital FocusedView → | localized triple-negative breast cancer | Phase 2 | Focused | View | |||
| NCT04292119 NCT04292119 · Massachusetts General Hospital FocusedView → | anaplastic lymphoma kinase-rearranged lung cancer | Phase 1/Phase 2 | Focused | View | |||